Advances in molecular and cellular therapies for hearing loss

Molecular Therapy

Volumn 16, Issue 2, 2008, Pages 224-236

  Hildebrand, Michael S ^a   Newton, Stephen S ^a   Gubbels, Samuel P ^a   Sheffield, Abraham M ^a,b   Kochhar, Amit ^a   de Silva, Michelle G ^c,d   Dahl, Hans Henrik M ^c,d   Rose, Scott D ^e   Behlke, Mark A ^e   Smith, Richard J H ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^e INTEGRATED DNA TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ANTIOXIDANT; BETA GALACTOSIDASE; BRAIN DERIVED NEUROTROPHIC FACTOR; CATALASE; CONNEXIN 31; ENHANCED GREEN FLUORESCENT PROTEIN; GENE PRODUCT; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCOCORTICOID; LENTIVIRUS VECTOR; LIPOSOME; NEUROTROPHIC FACTOR; PARVOVIRUS VECTOR; PROTEIN ATOH1; PROTEIN MYO15A; PROTEIN NT3; SCATTER FACTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

CELL LOSS; CELL THERAPY; CLINICAL EFFECTIVENESS; COCHLEA; COCHLEA PROSTHESIS; DEGENERATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG SPECIFICITY; EAR INJURY; EXPERIMENTAL MODEL; GENE REPRESSION; GENE TARGETING; GENETIC DISORDER; GRAFT REJECTION; HAIR CELL; HEARING LOSS; HUMAN; IMMUNOGENICITY; IN UTERO STEM CELL TRANSPLANTATION; INNER EAR; MAMMAL; MOLECULAR THERAPY; NERVE REGENERATION; NONHUMAN; NONVIRAL GENE THERAPY; OTOTOXICITY; PATIENT SAFETY; PERCEPTION DEAFNESS; REGENERATIVE ABILITY; REVIEW; RNA INTERFERENCE; SPIRAL GANGLION; STEM CELL TRANSPLANTATION; SUBSTITUTION THERAPY; TRANSPLANTATION; UNSPECIFIED SIDE EFFECT; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY;

ANIMALIA; AVES; MAMMALIA; REPTILIA;

EID: 38649123054     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/sj.mt.6300351     Document Type: Review

References (145)

1. Davis, AC (1990). Epidemiological profile of hearing impairments: The scale and nature of the problem with special reference to the elderly. Acta Otolaryngol Suppl 476: 23-31.
2. Wilson, DH, Walsh, PG, Sanchez, L, Davis, AC, Taylor, AW, Tucker, G et al. (1999). The epidemiology of hearing impairment in an Australian adult population. Int J Epidemiol 28: 247-252.
3. Fortnum, HM, Summerfield, AQ, Marshall, DH, Davis, AC and Bamford, JM (2001). Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: Questionnaire based ascertainment study. BMJ 323: 536-540.
4. Karikoski, JO and Marttila, TI (1995). Prevalence of childhood hearing impairment in southern Finland. Scand Audiol 24: 237-241.
5. Maki-Torkko, EM, Lindholm, PK, Vayrynen, MR, Leisti, JT and Somi, MJ (1998). Epidemiology of moderate to profound childhood hearing impairments in northern Finland. Any changes in ten years? Scand Audiol 27: 95-103.
6. Van Naarden, K, Decoufle, P and Caldwell, K (1999). Prevalence and characteristics of children with serious hearing impairment in metropolitan Atlanta, 1991-1993. Pediatrics 103: 570-575.
7. Bogardus, ST Jr, Yueh, B and Shekelle, PG (2003). Screening and management of adult hearing loss in primary care: Clinical applications. JAMA 289: 1986-1990.
8. Van Camp, G and Smith, RJ (2006). Hereditary Hearing Loss Homepage. http://webh01.ua.ac.be/hhh
9. Petit, C (2006). From deafness genes to hearing mechanisms: Harmony and counterpoint. Trends Mol Med 12: 57-64.
10. Fire, A, Xu, S, Montgomery, MK, Kostas, SA, Driver, SE and Mello, CC (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391: 806-811.
11. Novina, CD and Sharp, PA (2004). The RNAi revolution. Nature 430: 161-164.
12. Elbashir, SM, Harborth, J, Lendeckel, W, Yalcin, A, Weber, K and Tuschl, T (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411: 494-498.
13. Sullivan, CS and Ganem, D (200S). A vinus-encoded inhibitor that blocks RNA interference in mammalian cells. J Virol 79: 7371-7379.
14. Bennasser, Y, Le, SY, Benkirane, M and Jeang, KT (2005). Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22: 607-619.
15. Cullen, BR (2006). Is RNA interference involved in intrinsic antiviral immunity in mammals? Nat Immunol 7: 563-567.
16. Ambros, V (2004). The functions of animal microRNAs. Nature 431 350-355.
17. Dorn, G, Abdel'Al, S, Natt, FJ, Weiler, J, Hall, J, Meigel, I et al. (2001). Specific inhibition of the rat ligand-gated ion channel P2X3 function via methoxyethoxy-modified phosphorothioated antisense oligonucleotides. Antisense Nucleic Acid Drug Dev 11: 165-174.
18. Hemmings-Mieszczak, M, Dom, G, Natt, FJ, Hall, J and Wishart, WL (2003). Independent combinatorial effect of antisense oligonucleotides and RNAi-mediated specific inhibition of the recombinant rat P2X3 receptor. Nucleic Acids Res 31: 2117-2126.
19. Elbashir, SM, Lendeckel, W and Tuschl, T (2001). RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15: 188-200.
20. Vickers, TA, Koo, S, Bennett, CF, Crooke, ST, Dean, NM and Baker, BF (2003). Efficient reduction of target RNAs by small interfering RNA and RNase H-dependent antisense agents. A comparative analysis. J Biol Chem 278 7108-7118.
21. Behlke, MA (2006). Progress towards in vivo use of siRNAs. Mol Ther 13: 644-670.
22. Pei, Y and Tuschl, T (2006). On the art of identifying effective and specific siRNAs. Nat Methods 3: 670-676.
23. Peek, AS and Behlke, MA (2007). Design of active small interfering RNAs. Curr Opin Mol Ther 9: 110-118.
24. Brummelkamp, TR, Bernards, R and Agami, R (2002). Stable suppression of tumorigenicity by vinus-mediated RNA interference. Cancer Cell 2: 243-247.
25. Ding, H, Schwarz, DS, Keene, A, Affar el, B, Fenton, L, Xia, X et al. (2003). Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2: 209-217.
26. Gonzalez-Alegre, P, Bode, N, Davidson, BL and Paulson, HL (2005). Silencing primary dystonia: Lentiviral-mediated RNA interference therapy for DYT1 dystonia. J Neurosci 25: 10502-10509.
27. Miller, VM, Xia, H, Marrs, GL, Gouvion, CM, Lee, G, Davidson, BL et al. (2003). Allele-specific silencing of dominant disease genes. Proc Natl-Acad Sci USA 100: 7195-7200.
28. Du, Q, Thonberg, H, Wang, J, Wahlestedt, C and Liang, Z (2005). A systematic analysis of the silencing effects of an active siRNA at all single-nucleoticie mismatched target sites. Nucleic Acids Res 33: 1671-1677.
29. Schwarz, DS, Ding, H, Kennington, L, Moore, JT, Schelter, J, Burchard, J et al. (2006). Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2: E140.
30. Bermingham, NA, Hassan, BA, Price, SD, Vollrath, MA, Ben-Arie, N, Eatock, RA et al. (1999). Math1: An essential gene for the generation of inner ear hair cells. Science 284: 1837-1841.
31. Kawamoto, K, Ishimoto, S, Minoda, R, Brough, DE and Raphael, Y (2003). Math1 gene transfer generates new cochlear hair cells in mature guinea pigs in vivo. J Neurosci 23: 4395-4400.
32. Woods, C, Montcouquiol, M and Kelley, MW (2004). Math1 regulates development of the sensory epithelium in the mammalian cochlea. Nat Neurosci 7: 1310-1318.
33. Izumikawa, M, Minoda, R, Kawarnoto, K, Abrashkin, KA, Swiderski, DL, Dolan, DF et al. (2005). Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 11: 271-276.
34. Boviatsis, EJ, Chase, M, Wei, MX, Tamiya, T, Hurford, RK Jr, Kowall, NW et al. (1994). Gene transfer into experimental brain tumors mediated by adenovirus, herpes simplex virus, and retrovirus vectors. Hum Gene Ther 5: 183-191.
35. Wu, Z, Asokan, A and Samulski, RJ (2006). Adeno-associated virus-serotypes: Vector toolkit for human gene therapy. Mol Ther 14: 316-327.
36. Bedrosian, JC, Gratton, MA, Brigande, JV, Tang, W, Landau J and Bennett, J (2006). In vivo delivery of recombinant viruses to the fetal murine cochlea: Transduction characteristics and long-term effects on auditory function. Mol Ther 14: 328-335.
37. Vigna, E and Naldini, L (2000). Lentiviral vectors: Excellent tools for experimental gene transfer and promising candidates for gene therapy. J Gene Med 2: 308-316.
38. Kho, ST, Pettis, RM, Mhatre, AN and Lalwani, AK (2000). Cochlear microinjection and its effects upon auditory function in the guinea pig. Eur Arch Otochinolaryngol 257: 469-472.
39. Igro, J, Mhatre, AN, Tseng, CJ, Stern, RE, Coling, DE, Goldstein, JA et al. (2001). Cochlear gene delivery through an intact round window membrane in mouse. Hum Gene Ther 12: 539-548.
40. Jero, J, Tseng, CJ, Mhatre, AN and Lalwani, AK (2001). A surgical approach appropriate for targeted cochlear gene therapy in the mouse. Hear Res 151: 106-114.
41. Luebke, AE, Foster, PK, Muller, CD and Reel, AL (2001). Cochlear function and transgene expression in the guinea pig cochlea, using adenovirus and adeno-associated virus-directed gene transfer. Hum Gene Ther 12: 773-781.
42. Pickles, J (2001). An Introduction to the Physiology of Hearing. 2nd edn Academic Press Ltd.: London 27-29.
43. Morgan, G and Wooding, FB (1983). Cell migration in the ruminant placenta: A freeze-fracture study. J Ultrastruct Res 83: 148-160.
44. Wooding, FB, Morgan, G, Brandon, MR and Camous, S (1994). Membrane dynamics during migration of placental cells through trophectodermal tight junctions in sheep and goats. Cell Tissue Res 276: 387-397.
45. Soudais, C, Boutin, S, Hong, SS, Chillon, M, Danos, O, Bergetson, JM et al. (2000). Canine adenavirus type 2 attachment and internalization: Coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol 74: 10639-10649.
46. Qiu, J, Handa, A, Kirby, M and Brown, KE (2000). The interaction of heparin sulfate and adeno-associated virus 2. Virology 269: 137-147.
47. Carson, SD (2000). Limited proteolysis of the coxsackievirus and adenovirus receptor (CAR) on HeLa cells exposed to trypsin. FEBS Lett 484: 149-152.
48. Juhn, SK (1988). Barrier systems in the inner ear. Acta Otolaryngol Suppl 458: 79-83.
49. Lin, DW and Trune, DR (1997). Breakdown of stria vascularis blood-labyrinth barrier in C3H/lpr autoimmune disease mice. Otolaryngol Head Neck Surg 117: 530-534.
50. Trune, DR (1997). Cochlear immunoglobulin in the C3H/lpr mouse model for autoimmune hearing loss. Otolaryngol Head Neck Surg 117: 504-508.
51. Marques, JT and Wiliams, BR (2005). Activation of the mammalian immune system by siRNAs. Nat Biotechnol 23: 1399-1405.
52. Schlee, M, Hornung, V and Hartmann, G (2006). siRNA and isRNA: Two edges of one sword. Mol Ther 14: 463-470.
53. Judge, AD, Bola, G, Lee, AC and MacLachlan, I (2006). Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. Mol Ther 13: 494-505.
54. Stover, T, Yagi, M and Raphael, Y (2000). Transduction of the contralateral ear after adenovirus-mediated cochlear gene transfer. Gene Ther 7: 377-383.
55. Kho, ST, Pettis, RM, Mhatre, AN and Lalwani, AK (2000). Safety of adeno-associated virus as cochlear gene transfer vector: Analysis of distant spread beyond injected. cochleae. Mol Ther 2: 368-373.
56. Han, JJ, Mhatre, AN, Wareing, M, Pettis, R, Gao, WQ, Zufferey, RN et al. (1999). Transgene expression in the guinea pig cochlea mediated by a lentivirus-derived gene transfer vector. Hum Gene Ther 10 1867-1873.
57. Xia, JH, Liu, CY, Tang, BS, Pan, Q, Huang, L, Dai, HP et al. (1998). Mutations in the gene encoding gap junction protein beta-3 associated with autosomal dominant hearing impairment. Nat Genet 20: 370-373.
58. Kelsell, DP, Dunlop, J, Stevens, HP, Lench, NJ, Liang, JN, Parry, G et al. (1997). Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 387: 80-83.
59. Grifa, A, Wagner, CA, D'Ambrosio, L, Melchionda, S, Bernardi, F, Lopez-Bigas, N et al. (1999). Mutations in GJB6 cause nonsyndromic autosomal dominant deafness at DFNA3 locus. Nat Genet 23: 16-18.
60. Maeda, Y, Fukushima, K, Nishizaki, K and Smith, RJ (2005). In vitro and in vivo suppression of GJB2 expression by RNA interference. Hum Mol Genet 14: 1641-1650.
61. Kudo, T, Kure, S, Ikeda, K, Xia, AP, Katori, Y, Suzuki, M et al. (2003). Transgenic expression of a dominant-negative connexin26 causes degeneration of the organ of Corti and non-syndromic deafness. Hum Mol Genet 12: 995-1004.
62. Yamanishi, T, Katsu, K, Funahashi, J, Yumoto, E and Yokouchi, Y (2007). Dan is required for normal morphogenesis and patterning in the developing chick inner ear. Dev Growth Differ 49: 13-26.
63. So, HS, Kim, HJ, Lee, JH, Park, SY, Park, C, Kim, YH et al. (2006). Flunarizine induces Nrf2-mediated transcriptional activation of heme oxygenase-1 in protection of auditory cells from cisplatin. Cell Death Differ 13: 1763-1775.
64. Kim, HJ, So, HS, Lee, JH, Park, C, Park, SY, Kim, YH et al. (2006). Heme oxygenase-1 attenuates the cisplatin-induced apoptosis of auditory cells via down-regulation of reactive oxygen species generation. Free Radic Biol Med 40: 1810-1819.
65. Kanzaki, S, Beyer, L, Karolyi, IJ, Dolan, DF, Fang, Q. Probst, FJ et al. (2006). Transgene correction maintains normal cochlear structure and function in 6-month-old Myo1 5a mutant mice. Hear Res 214 37-44.
66. Spoendlin, H (1975). Neuroanatomical basis of cochlear coding mechanisms. Audiology 14: 383-407.
67. Iyung, RW, Miller, JM and Cannon, SC (1989). Evaluation of eighth nerve integrity by the electrically evoked middle latency response. Otolaryngol Head Neck Surg 101: 670-682.
68. Ghorayer, B, Sarwat, A and Linthicum, FH Jr (1980). Viable spiral ganglion cells in congenital and acquired profound hearing loss. J Laryngol Otol 94: 367-376.
69. 2+]i within a set range. J Neurosci 17: 1959-1970.
70. Hansen, MR, Zha, XM, Bok, J and Green, SH (2001). Multiple distinct signal pathways, including an autocrine neurotrophic mechanism, contribute to the survival-promoting effect of depolarization on spiral ganglion neurons in vitro. J Neurosci 21: 2256-2267.
71. Clopton, BM, Spelman, FA and Miller, JM (1980). Estimates of essential neural elements for stimulation through a cochlear prosthesis. Ann Otol Rhinol Laryngol Suppl 89: 5-7.
72. Kerr, A and Schuknecht, HF (1968). The spiral ganglion in profound deafness. Acta Otolaryngol Suppl 65: 586-598.
73. Otte, J, Schunknecht, HF and Kerr, AG (1978). Ganglion cell populations in normal and pathological human cochleae. Implications for cochlear implantation. Laryngoscope 88: 1231-1246.
74. Fritzsch, B, Pirvola, U and Ylikoski, J (1999). Making and breaking the innervation of the ear: Neurotrophic support during ear development and its clinical implications. Cell Tissue Res 295: 369-382.
75. Fritzsch, B, Barbacid, M and Silos-Santiago, I (1998). The combined effects of trkB and trkC mutations on the innervation of the inner ear. Int J Dev Neurosci 16: 493-505.
76. Staecker, H, Kopke, R, Malgrange, B, Lefebvre, P and Van de Water, TR (1996). NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 7: 889-894.
77. Ernfors, P, Van De Water, T, Loring, J and Jaenisch, R (1995). Complementary roles of BDNF and NT-3 in vestibular and auditory development. Neuron 14: 1153-1164.
78. Miller, JM, Chi, DH, O'Keeffe, LJ, Kruszka, P, Raphael, Y and Altschuler, RA (1997). Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. Int J Dev Neurosci 15: 631-643.
79. Yagi, M, Kanzaki, S, Kawamoto, K, Shin, B, Shah, PP, Magal, E et al. (2000). Spiral ganglion neurons are protected from degeneration by GDNF gene therapy. J Assoc Res Otolaryngol 1: 315-325.
80. Oshima, K, Shimamura, M, Mizuno, S, Tamai, K, Doi, K, Morishita, R et al. (2004). Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. FASEB J 18: 212-214.
81. Nakaizumi, T, Kawamoto, K, Minoda, R and Raphael, Y (2004). Adenovirus-mediated expression of brain-derived neurotrophic factor protects spiral ganglion neurons from ototoxic damage. Audiol Neurootol 9: 135-143.
82. Okano, T, Nakagawa, T, Kita, T, Endo, T and Ito, J (2006). Cell-gene delivery of brain-derived neurotrophic factor to the mouse inner ear. Mol Ther 14: 866-871.
83. Rejali, D, Lee, VA, Abrashkin, KA, Humayun, N, Swiderski, DL and Raphael, Y (2007). Cochlear implants and ex vivo BDNF gene therapy protect spiral ganglion neurons. Hear Res 228: 180-187.
84. Lamm, K and Arnold, W (1999). Successful treatment of noise-induced cochlear ischemia, hypoxia, and hearing loss. Ann NY Acad Sci 884: 233-248.
85. Pondugula, SR, Raveendran, NN, Ergonul, Z, Deng, Y, Chen, J, Sanneman, JD et al. (2006). Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiol Genomics 24: 114-123.
86. Kokotas, H, Petersen, MB and Willems, PJ (2007). Mitochondrial deafness. Clin Genet 71: 379-391.
87. Pickles, JO (2004). Mutation in mitochondrial DNA as a cause of presbyacusis. Audiol Neurootol 9: 23-33.
88. Sha, SH and Schacht, J (1999). Stimulation of free radical formation by aminoglycoside antibiotics. Hear Res 128: 112-118.
89. Le Prell, CG, Dolan, DF, Schacht, J, Miller, JM, Lomax, MI and Altschuler, RA (2003). Pathways for protection from noise induced hearing loss. Noise Health 5: 1-17.
90. Kawamoto, K, Sha, SH, Minoda, R, Izumikawa, M, Kuriyama, H, Schacht, J et al. (2004). Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther 9: 173-181.
91. Pickles, JO (2004). Mutation in mitochondrial DNA as a cause of presbyacusis. Audlol Neurootol 9: 23-33.
92. Vats, A, Tolley, NS, Polak, JM and Buttery, LD (2002). Stem cells: sources and applications. Clin Otolaryngol 27: 227-232.
93. De Bari, C, Dell'Accio, F, Vandenabeele, F, Vermeesch, JR, Raymackers, JM and Luyten, FP (2003). Skeletal muscle repair by adult human mesenchymal stem cells from synovial membrane. J Cell Biol 160 909-918.
94. Ishiwata, I, Tokeida, Y, Iguchi, M, Ishiwata, C, Kiguchi, K, Yasumoto, S et al. (2001). New approach for the establishment of mouse early embryonic stem cells and induction of their differentiation. Hum Cell 14: 283-291.
95. Rideout, WM, Hochedlinger, K, Kyba, M, Daley, GQ and Jaenich, R (2002). Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 109: 17-27.
96. Bjorklund, LM, Sanchez-Pemaute, R, Chung, S, Andersson, T, Chen, IY, McNaught, KS et al. (2001). Embryonic stem cells develop into functional dopaminergic neurons after transplantation in a Parkinson rat model. Proc Natl Acad Sci USA 99: 2344-2349.
97. Gage, FH, Coates, PW, Palmer, TD, Kuhn, HG, Fisher, LJ, Suhonen, JO et al. (1995). Survival and differentiation of adult neuronal progenitor cells transplanted to the adult brain. Proc Natl Acad Sci USA 92: 11879-11883.
98. Gage, FH, Ray, J and Fisher, LJ (1995). Isolation, characterization, and use of stem cells from the CNS. Annu Rev Neurosci 18: 159-192.
99. Suhonen, JO, Petersen, DA, Ray, J and Gage, FH (1996). Differentiation of adult hippocampus-derived progenitors into olfactory neurons in vivo. Nature 383: 624-627.
100. Orlic, D (2003). Adult bone marrow stem cells regenerate myocardium in ischemic heart disease. Ann-NY Acad Sci 996: 152-157.
101. Korbling, M and Estrov, Z (2003). Adult stem cells for tissue repair - a new therapeutic concept? N Engl J Med 349: 570-582.
102. Jackson, KA, Majka, SM, Wang, H, Pocius, J, Hartley, CJ, Majesky, MW et al. (2001). Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107: 1395-1402.
103. Salvi, RJ, Wang, J and Ding, D (2000). Auditory plasticity and hyperactivity following cochlear damage. Hear Res 147: 261-274.
104. Palomar Garcia, V, Abdulghani Martinez, F, Bodet Agusti, E, Andreu Mencia, L and Palomar Asenjo, V (2001). Drug-induced otoxicity: Current status. Acta Otolaryngol Suppl 121: 569-572.
105. Kubisch, C, Schroeder, BC, Friedrich, T, Lutjohann, B, El-Amraoui, A, Marlin, S et al. (1999). KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96: 437-446.
106. Wang, A, Liang, Y, Fridell, RA, Probst, FJ, Wilcox, ER, Touchman, JW et al. (1998). Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. Science 280: 1447-1451.
107. Vahava, O, Morell, R, Lynch, ED, Weiss, S, Kagan, ME, Ahituv, N et al. (1998). Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science 279: 1950-1954.
108. Warchol, ME and Corwin, JT (1996). Regenerative proliferation in organ cultures of the avian cochlea: Identification of the initial progenitors and determination of the latency of the proliferative response. J Neurosci 16: 5466-5477.
109. Staecker, H and Van De Water, TR (1998). Factors controlling hair-cell regeneration/repair in the inner ear. Curr Opin Neurobiol 8: 480-487.
110. Warchol, ME, Lambert, PR, Goldstein, BJ, Forge, A and Corwin, JT (1993). Regenerative proliferation in inner ear sensory epithelia from adult guinea pigs and humans. Science 259: 1619-1622.
111. Forge, A, Li, L, Corwin, JT and Nevill, G (1993). ultrastructural evidence for hair cell regeneration in the mammalian inner ear. Science 259: 1616-1619.
112. Zheng, JL and Gao, WQ (2000). Overexpression of Math 1 induces robust production of extra hair cells in postnatal rat inner ears. Nat Neurosci 3: 580-586.
113. Ito, J, Kojima, K and Kawaguchi, S (2001). Survival of neural stem cells in the cochlea. Acta Otolaryngol Suppl 121: 140-142.
114. Tateya, I, Nakagawa, T, Iguchi, F, Kim, TS, Endo, T, Yamada, S et al. (2003). Fate of neural stem cells grafted into injured inner ears of mice. Neuroreport 14: 1677-1681.
115. Sakamoto, T, Nakagawa, T, Endo, T, Kim, TS, Iguchi, F, Naito, Y et al. (2004). Fates of mouse embryonic stem cells transplanted into the inner ears of adult mice and embryonic chickens. Acta Otolaryngol Suppl 48-52.
116. Hu, Z, Ulfendahl, M and Olivius, NP (2004). Central migration of neuronal tissue and embryonic stem cells following transplantation along the adult auditory nerve. Brain Res 1026: 68-73.
117. Hildebrand, M, Dahl, H-H, Hardman, J, Coleman, B, Shepherd, R and de Silva, M (2005). Survival of partially differentiated mouse embryonic stem cells in the scala media of the guinea pig cochlea. J Assoc Res Otolaryngol 6: 341-354.
118. Lang, H, Ebihara, Y, Schmiedt, RA, Minamiguchi, H, Zhou, D, Smythe, N et al. (2006). Contribution of bone marrow hematopoietic stem cells to adult mouse inner ear mesenchymal cells and fibrocytes. J Comp Neurol 496: 187-201.
119. Matsuoka, AJ, Kondo, T, Miyamoto, RT and Hashino, E (2006). In vivo and in vitro characterization of bone marrow-derived stem cells in the cochlea. Laryngoscope 116: 1363-1367.
120. Corrales, CE, Pan, L, Li, H, Liberman, MC, Heller, S and Edge, AS (2006). Engraftment and differentiation of embryonic stem cell-derived neural progenitor cells in the cochlear nerve trunk: Growth of processes into the organ of Corti. J Neurobiol 66: 1489-1500.
121. Takeuchi, S, Takeda, T and Saito, H (1991). Pressure relationship between perilymph and endolymph associated with endolymphatic infusion. Ann Otol Rhinol Laryngol 100: 244-248.
122. Salt, AN and DeMott, JE (1998). Longitudinal endolymph movements induced by perilymphatic injections. Hear Res 123: 137-147.
123. Kakigi, A and Takeda, T (1998). Effect of artificial endolymph injection into the cochlear duct on the endocochlear potential. Hear Res 116: 113-118.
124. Iguchi, F, Nakagawa, T, Tateya, I, Kim, TS, Endo, T, Taniguchi, Z et al. (2003). Trophic support of mouse inner ear by neural stem cell transplantation. Neuroreport 14: 77-80.
125. Isacson, O and Deacon, TW (1996). Specific axon guidance factors persist in the adult brain as demonstrated by pig neuroblasts transplanted to the rat. Neuroscience 75: 827-837.
126. Gray, JA, Hodges, H and Sinden, J (1999). Prospects for the clinical application of neural transplantation with the use of conditionally immortalized neuroepithelial stem cells. Philos Trans R Soc Land B Biol Sci 354: 1407-1421.
127. Qu, T, Brannen, CL, Kim, HM and Sugaya, K (2001). Human neural stem cells improve cognitive function of aged brain. Neuroreport 12 1127-1132.
128. Han, D, Yu, Z, Fan, E, Liu, C, Liu, S, Li, Y et al. (2004). Morphology of auditory hair cells in guinea pig cochlea after transgene expression. Hear Res 190: 25-30.
129. Deng, Z, Wang, J, Qiu, J, Liu, S, Wang, C and Yang, (2004). [Protection of NT3 gene transfection on the guinea pig cochlea treated with gentamicin]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 18: 231-233.
130. Liu, Y, Okada, T, Sheykholeslami, K, Shimazaki, K, Nomoto, T, Muramatsu, S et al. (2005). Specific and efficient transduction of cochlear inner hair cells with recombinant adeno-associated virus type 3 vector. Mol Ther 12: 725-733.
131. Iwai, H, Lee, S, Inaba, M, Sugiura, K, Tomoda, K, Yamashita, T et al. (2001). Prevention of accelerated presbycusis. by bone marrow transplantation in senescence-accelerated mice. Bone Marrow Transplant 28: 323-328.
132. Olivius, P, Alexandrov, L, Miller, J, Ulfendahl, M, Bagger-Sjoback, D and Kozlova, EN (2003). Allografted fetal dorsal root ganglion neuronal survival in the guinea pig cochlea. Brain Res 279: 1-6.
133. Naito, Y, Nakamura, T, Nakagawa, T, Iguchi, F, Endo, T, Fujino, K et al. (2004). Transplantation of bone marrow stromal cells into the cochlea of chinchillas. Neuroreport 15: 1-4.
134. Tamura, T, Nakagawa, T, Iguchi, F, Tateya, I, Endo, T, Kim, TS et al. (2004). Transplantation of neural stem cells into the modiolus of mouse cochleae injured by cisplatin. Acta Otolaryngol Suppl 65-68.
135. Kojima, K, Murata, M, Nishio, T, Kawaguchi, S and Ito, I (2004). Survival of fetal rat otocyst cells grafted into the damaged inner ear. Acta Otolaryngol Suppl 53-55.
136. Hu, Z, Uffendahl, M and Olivius, NP (2004). Survival of neuronal tissue following xenograft implantation into the adult rat inner ear. Exp Neurol 185: 7-14.
137. Hu, Z, Ulfendahl, M and Olivius, NP (2005). NGF stimulates extensive neurite outgrowth from implanted dorsal root ganglion neurons following transplantation into the adult rat inner ear. Neurobiol Dis 18 184-192.
138. Regala, C, Duan, M, Zou, J, Salminen, M and Olivius, P (2005). Xenografted fetal dorsal root ganglion, embryonic stem cell and adult neural stem cell survival following implantation into the adult vestibulocochlear nerve. Exp Neurol 193: 326-333.
139. Hu, Z, Wei, D, Johansson, CB, Holmstrom, N, Duan, M, Frisen, J et al. (2005). Survival and neural differentiation of adult neural stem cells transplanted into the mature inner ear. Exp Cell Res 302 40-47.
140. Coleman, B, Hardman, J, Coco, A, Epp, S, de Silva, M, Crook, J et al. (2006). Fate of embryonic stem cell transplanted into the deafened mammalian cochlea. Cell Transplant 15: 369-380.
141. Okano, T, Nakagawa, T, Endo, T, Kim, TS, Kita, T, Tamura, T et al. (2005). Engraftment of embryonic stem cell-derived neurons into the cochlear modiolus. Neuroreport 16: 1919-1922.
142. Sekiya, T, Kojima, K, Matsumoto, M, Kim, TS, Tamura, T and Ito, J (2006). Cell transplantation to the auditory nerve and cochlear duct, Exp Neurol 198: 12-24.
143. Smith, RJ, Bale, J, Jr, and White, KR (2005). Sensorineural hearing loss in children. Lancet 365: 879-890.
144. + conduction and selectivity. Science 280 69-77.
145. Hildebrand, MS, de Silva, MG, Klockan, T, Solares, CA Hirose, K, Smith, JD et al. (2005). Expression of the carrier protein apolipoprotein D in the mouse inner ear. Hear Res 200: 102-114.